Ep. 48: Understanding the Dezawa Protocol: Why Standardization Matters

Understanding the Dezawa Protocol: Why Standardization Matters

Patients at STEMS Health often ask Drs. Ankeet Choxi and Jarred Mait a version of the same question. If Muse cells are so rare, how does anyone actually isolate them consistently? The answer comes down to something called the Dezawa Protocol, and it is a bigger deal than most people realize.

The Dezawa Protocol is the validated laboratory methodology developed by Professor Mari Dezawa's team for identifying and isolating Muse cells from a broader population of mesenchymal stem cells. It is not a product. It is a process, and that distinction matters enormously in medicine. A discovery is only as useful in the clinic as the method used to reproduce it reliably, batch after batch, lab after lab.

Here is why that is such a challenge in the first place. Muse cells make up a small percentage of any given stem cell culture. You cannot just look at cells under a microscope and pick out the right ones. The protocol solves this by relying on specific, defined markers, most notably something called SSEA three, a marker linked to pluripotent like cells. It also specifies the exact culture conditions needed to preserve the cells' natural stress tolerant characteristics through processing. Without that level of specificity, one lab's version of a Muse cell could end up meaningfully different from another lab's version, even if both used the same name.

This is also where things shift from a research protocol into a manufacturing standard. Producing cells for actual clinical use means adding sterility standards, documentation, and quality control checkpoints at every stage, well beyond what is needed to publish an academic paper. That layer of oversight is what allows a manufactured product to stay tied to the same research base it claims to represent, rather than drifting into something else entirely over time.

This is exactly why Doctors Choxi and Mait encourage patients to ask specific questions before choosing a treatment. Is this based on Dezawa's actual validated protocol, or something using similar language without the same process behind it? What quality control measures are actually in place? These are not rhetorical questions. The answers tell you whether a treatment is grounded in reproducible science, or just borrowing familiar terminology.

Manufacturing consistency will not answer every question about whether a treatment is right for you, but it is one of the clearest signals of scientific credibility available. Protocols like this one are not necessarily fixed forever either. As research continues, methodologies are sometimes refined to address new questions about long term consistency and stability, which is a normal part of how any area of regenerative medicine matures over time. If you want to understand exactly how this applies to a treatment you are considering, reach out to STEMS Health and talk with our team directly.